| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 6 |
| 1 | ADALIMUMAB | 5 |
| 2 | IBUPROFEN | 5 |
| 3 | LAMOTRIGINE | 5 |
| 4 | LEVOTHYROXINE SODIUM | 5 |
| 5 | ALENDRONATE SODIUM | 4 |
| 6 | GABAPENTIN | 4 |
| 7 | METHOTREXATE | 4 |
| 8 | METHOTREXATE SODIUM | 4 |
| 9 | OMEPRAZOLE MAGNESIUM | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LARONIDASE | 2 | 0.0005 |
| 1 | ZANAMIVIR | 1 | 0.0004 |
| 2 | CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE | 1 | 0.0003 |
| 3 | FILGRASTIM-SNDZ | 1 | 0.0003 |
| 4 | FEXOFENADINE HCL | 1 | 0.0003 |
| 5 | PENTOXIFYLLINE | 1 | 0.0002 |
| 6 | TEMSIROLIMUS | 1 | 0.0002 |
| 7 | ELOSULFASE ALFA | 1 | 0.0002 |
| 8 | OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN | 2 | 0.0002 |
| 9 | PANITUMUMAB | 2 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Neuraminidase Inhibitor [EPC] | 1 | 0.0004 |
| 1 | Sulfonamide Antibacterial [EPC] | 1 | 0.0003 |
| 2 | Blood Viscosity Reducer [EPC] | 1 | 0.0002 |
| 3 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 3 | 0.0002 |
| 4 | Provitamin D2 Compound [EPC] | 3 | 0.0001 |
| 5 | CD19-directed Chimeric Antigen Receptor [EPC] | 1 | 0.0001 |
| 6 | Asparagine-specific Enzyme [EPC] | 1 | 0.0001 |
| 7 | Bile Acid [EPC] | 1 | 0.0000 |
| 8 | Epidermal Growth Factor Receptor Antagonist [EPC] | 2 | 0.0000 |
| 9 | Antimycobacterial [EPC] | 1 | 0.0000 |